Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider

The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

AI generates short DNA sequences that show promise for gene therapies

Scientists at the Broad Institute and Mass General Brigham have built a generative AI model that creates short DNA segments ...

Using AI to keep CRISPR technology in-check

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

10X Health System and Verséa Discovery Launch 10X MitoScreen(TM), a Next-Generation Mitochondrial Assessment Test

X Health System, a precision wellness company focused on data-driven human optimization, today announced the addition of 10X MitoScreen (TM), an advanced mitochondrial health assessment, through a ...

Lab-grown mini-stomachs could boost understanding of rare diseases

Researchers at UCL and Great Ormond Street Hospital (GOSH) have developed the first-ever lab-grown mini-stomach that contains ...

A skin biopsy can detect a rare neurodegenerative disease

By determining the structure of the deposits responsible for transthyretin amyloidosis through a simple skin biopsy, scientists at UNIGE are paving the way for a new diagnostic method for ...
Technology Networks

Digital CRISPR Assay Tracks Fungal Load and AMR in 40 Minutes

Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal resistance in under 40 minutes. The assay provides rapid, precise results from ...